Agilent (NYSE:A) Rating Upped
Agilent (NYSE:A)’s stock was increased to “Overweight” by professional analysts at Morgan Stanley. A’s “Equal-Weight” rating is no longer valid.
Despite the stock upgrade NYSE:A is right now trading -0.46% lower at $52.21 as of 2:01 AM New York time. Agilent shares have [From2] 0% over the last 200 days, while the Standard & Poor’s 500 index has increased 13.17% in the same time.
Out of 14 analysts covering Agilent, 10 rate it a Buy, 6 indicate a Hold while 0 suggest a Sell. The highest target is $50 and the lowest is $42 according to Thomson/First Call. The 12-month mean target is $45.86, which means downside potential of 12.16% over the current price.
Lombard Odier Asset Management (Switzerland) Sa had the most significant stake with ownership of 457,000 shares as of Q2 2015 for 5.14% of the fund portfolio. Robecosam Usa Inc. is another bull as the fund who is possessing 85,514 shares of Agilent or 4.79% of their fund portfolio. In addition, Impax Asset Management Ltd have 3.52% of their fund portfolio invested in the company for 1.63M shares. The New York-based fund Cantillon Capital Management Llc disclosed it had purchased a stake worth about 2.98% of the fund’s stock portfolio in Agilent. The Switzerland-based fund Robecosam Ag is also positive about the stock, possessing 4.49M shares or 2.89% of their fund portfolio.
Agilent (NYSE:A) Profile
Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Agilent (NYSE:A) traded down -0.46% on 15 March, hitting $52.21. A total of shares of the company’s stock traded hands. This is down from average of 1.99M shares. Agilent has a 52 week low of $38.02 and a 52 week high of $52.46. The company has a market cap of $16.92B and a P/E ratio of 33.6.
Get the latest Agilent (NYSE:A) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.
The post Agilent (NYSE:A) Upgraded at Morgan Stanley to “Equal-Weight” from “Equal-Weight” Rating appeared first on Octafinance.